Cross-disease transcriptomic meta-analysis and network pharmacology reveal key therapeutic targets in rheumatoid arthritis, systemic lupus erythematosus and multiple sclerosis. - K. Lakshmi 006; Vino Sundararajan (Frontiers Bioinform., 2026)